Tag: Sun Pharma
Synopsis: Sun Pharma is in focus on a potential $12 billion Organon deal and biosimilars push, seen as a key growth driver supporting global expansion, diversification, and earnings upside. The…
Synopsis: Sun Pharma is in focus on a potential $12 billion Organon deal and biosimilars push, seen as a key growth driver supporting global expansion, diversification, and earnings upside. The…